NAVB Key Stats
- NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Yahoo 03/11 17:14 ET
- Navidea: The Future Of The Company Will Be Borne On The Back Of Lymphoseek Yahoo 03/11 11:17 ET
- NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Mat Yahoo 03/07 16:39 ET
- Why Navidea Biopharmaceuticals, Inc. Shares Jumped Yahoo 03/06 15:21 ET
- Aegis Capital Lifts PT on Navidea Biopharma (NAVB) to $2.50; Lymphoseek Sales Encouraging Street Insider 03/06 15:18 ET
- Navidea Biopharmaceuticals, Inc Management Discusses Q4 2013 Results - Earnings Call Transcript Seeking Alpha 03/06 11:50 ET
- Navidea closes $30M loan with Oxford, issues warrants for 391K shares Yahoo 03/06 08:54 ET
- Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Yahoo 03/06 08:30 ET
- Navidea Biopharmaceuticals Discusses Q4 2013 Results (Webcast) Seeking Alpha 03/06 08:25 ET
- Navidea Biopharmaceuticals Closes $30 Million Loan with Oxford Finance, LLC noodls 03/06 08:11 ET
NAVB Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Navidea Biopharmaceutical is down 39.59% over the last year vs S&P 500 Total Return up 24.21%, Cynosure up 2.15%, and Natus Medical up 94.81%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for NAVB
Pro Strategies Featuring NAVB
Did Navidea Biopharmaceutical make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Medical Devices
- Headquarters Country: United States
- Headquarters State/Province: Ohio
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Navidea Biopharmaceuticals Inc is a biomedical company which is engaged in the development and commercialization of surgical and diagnostic products.